Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A 15-year follow-up.

Tiippana-Kinnunen, T; Paimela, L; Kautiainen, H; Laasonen, L; Leirisalo-Repo, M

Tiippana-Kinnunen, T; Paimela, L; Kautiainen, H; Laasonen, L; Leirisalo-Repo, M.

Affiliation

Tiippana-Kinnunen T; Department of Medicine, Division of Rheumatology, Helsinki University Central Hospital, Helsinki, Finland. tarja.tiippana-kinnunen@hus.fi

Scand J Rheumatol ; 39(1): 12-8, 2010.

Article in En | MEDLINE | ID: mdl-20132065

Subject(s)

Antirheumatic Agents/administration & dosage; Arthritis, Rheumatoid/diagnosis; Arthritis, Rheumatoid/drug therapy; Quality of Life; Adult; Age of Onset; Arthritis, Rheumatoid/epidemiology; Chronic Disease; Cohort Studies; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Probability; Risk Assessment; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Quality of Life / Antirheumatic Agents Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Scand J Rheumatol Year: 2010 Document type: Article Affiliation country: Finland Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google